Published in J Biol Chem on November 29, 2013
Disulfide cross-linking of transport and trimerization domains of a neuronal glutamate transporter restricts the role of the substrate to the gating of the anion conductance. J Biol Chem (2014) 0.94
Substrate-bound outward-open state of the betaine transporter BetP provides insights into Na+ coupling. Nat Commun (2014) 0.93
Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site. J Biol Chem (2014) 0.87
Two Na+ Sites Control Conformational Change in a Neurotransmitter Transporter Homolog. J Biol Chem (2015) 0.84
The second sodium site in the dopamine transporter controls cation permeation and is regulated by chloride. J Biol Chem (2014) 0.84
Electrogenic Binding of Intracellular Cations Defines a Kinetic Decision Point in the Transport Cycle of the Human Serotonin Transporter. J Biol Chem (2016) 0.79
Monoamine transporters: insights from molecular dynamics simulations. Front Pharmacol (2015) 0.79
Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine. J Pharmacol Exp Ther (2016) 0.77
Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes. Front Pharmacol (2016) 0.77
Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membrane. Nat Commun (2016) 0.75
VMD: visual molecular dynamics. J Mol Graph (1996) 117.02
GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theory Comput (2008) 34.90
Stereochemistry of polypeptide chain configurations. J Mol Biol (1963) 14.20
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters. Nature (2005) 12.56
Simple allosteric model for membrane pumps. Nature (1966) 7.78
Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet (1998) 5.85
The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na+/sugar symport. Science (2008) 4.94
A competitive inhibitor traps LeuT in an open-to-out conformation. Science (2008) 4.86
Novel procedure for modeling ligand/receptor induced fit effects. J Med Chem (2006) 4.74
LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science (2007) 4.08
Metal-ligand geometry relevant to proteins and in proteins: sodium and potassium. Acta Crystallogr D Biol Crystallogr (2002) 3.55
Structure and molecular mechanism of a nucleobase-cation-symport-1 family transporter. Science (2008) 3.39
Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol (1997) 3.36
Structure and mechanism of a Na+-independent amino acid transporter. Science (2009) 3.30
Molecular basis of transport and regulation in the Na(+)/betaine symporter BetP. Nature (2009) 3.27
Mechanism for alternating access in neurotransmitter transporters. Proc Natl Acad Sci U S A (2008) 3.24
X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature (2012) 3.24
A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function. Mol Pharmacol (2006) 3.23
Unlocking the molecular secrets of sodium-coupled transporters. Nature (2009) 3.23
SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev (2011) 3.03
X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature (2013) 3.00
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des (2013) 2.93
Cloning and expression of a functional serotonin transporter from rat brain. Nature (1991) 2.86
Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A (1993) 2.80
SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem (2011) 2.74
Molecular basis of alternating access membrane transport by the sodium-hydantoin transporter Mhp1. Science (2010) 2.52
Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat Neurosci (2002) 2.45
The rocking bundle: a mechanism for ion-coupled solute flux by symmetrical transporters. Physiology (Bethesda) (2009) 2.41
Structure and mechanism of an amino acid antiporter. Science (2009) 2.40
Identification of a chloride ion binding site in Na+/Cl -dependent transporters. Proc Natl Acad Sci U S A (2007) 2.32
Control of ion selectivity in LeuT: two Na+ binding sites with two different mechanisms. J Mol Biol (2008) 2.27
Mechanism of chloride interaction with neurotransmitter:sodium symporters. Nature (2007) 2.25
Cloning of a serotonin transporter affected by antidepressants. Science (1991) 2.12
Structure and function of Na(+)-symporters with inverted repeats. Curr Opin Struct Biol (2009) 2.10
External cysteine residues in the serotonin transporter. Biochemistry (1997) 2.01
Conducting states of a mammalian serotonin transporter. Neuron (1994) 1.96
The mechanism of sodium and substrate release from the binding pocket of vSGLT. Nature (2010) 1.74
The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding. J Biol Chem (1997) 1.62
Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I. J Biol Chem (2003) 1.60
Regulating the conducting states of a mammalian serotonin transporter. Neuron (2003) 1.55
Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter. J Neurosci (1999) 1.55
Dopamine transporters depolarize neurons by a channel mechanism. Proc Natl Acad Sci U S A (2004) 1.46
Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels. J Biol Chem (2011) 1.37
Structural basis of Na(+)-independent and cooperative substrate/product antiport in CaiT. Nature (2010) 1.36
Sodium-dependent accumulation of 5-hydroxytryptamine by rat blood platelets. Br J Pharmacol (1969) 1.35
Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies. Proteins (2009) 1.32
Ion-controlled conformational dynamics in the outward-open transition from an occluded state of LeuT. Biophys J (2012) 1.30
Conformational rearrangements to the intracellular open states of the LeuT and ApcT transporters are modulated by common mechanisms. Biophys J (2010) 1.27
Unifying concept of serotonin transporter-associated currents. J Biol Chem (2011) 1.24
The role of local hydration and hydrogen-bonding dynamics in ion and solute release from ion-coupled secondary transporters. Biochemistry (2011) 1.20
SLC6 transporters: structure, function, regulation, disease association and therapeutics. Mol Aspects Med (2013) 1.18
ATP stimulates sympathetic transmitter release via presynaptic P2X purinoceptors. J Neurosci (1999) 1.18
Coupling between platelet 5-hydroxytryptamine and potassium transport. J Biol Chem (1979) 1.17
Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter. J Biol Chem (2004) 1.13
Two mechanisms of ion selectivity in protein binding sites. Proc Natl Acad Sci U S A (2010) 1.12
Platelet 5-hydroxytryptamine transport, an electroneutral mechanism coupled to potassium. Biochemistry (1978) 1.12
Chloride binding site of neurotransmitter sodium symporters. Proc Natl Acad Sci U S A (2013) 1.09
Accessibility and conformational coupling in serotonin transporter predicted internal domains. J Neurosci (2002) 1.05
A lithium-induced conformational change in serotonin transporter alters cocaine binding, ion conductance, and reactivity of Cys-109. J Biol Chem (2001) 1.01
Investigation of the sodium-binding sites in the sodium-coupled betaine transporter BetP. Proc Natl Acad Sci U S A (2012) 1.01
Insights into transport mechanism from LeuT engineered to transport tryptophan. EMBO J (2011) 1.00
Unbiased simulations reveal the inward-facing conformation of the human serotonin transporter and Na(+) ion release. PLoS Comput Biol (2011) 1.00
A conformationally sensitive residue on the cytoplasmic surface of serotonin transporter. J Biol Chem (2001) 0.98
A conserved asparagine residue in transmembrane segment 1 (TM1) of serotonin transporter dictates chloride-coupled neurotransmitter transport. J Biol Chem (2011) 0.96
The role of chloride ion in platelet serotonin transport. J Biol Chem (1982) 0.94
Reconstructing a chloride-binding site in a bacterial neurotransmitter transporter homologue. J Biol Chem (2010) 0.93
A glutamine residue conserved in the neurotransmitter:sodium:symporters is essential for the interaction of chloride with the GABA transporter GAT-1. J Biol Chem (2010) 0.91
Atomistic models of ion and solute transport by the sodium-dependent secondary active transporters. Biochim Biophys Acta (2011) 0.83
Mechanistic analyses of ion dependences in a high-affinity human serotonin transport system in transfected murine fibroblast cells. J Physiol (1998) 0.81
S4-based voltage sensors have three major conformations. Proc Natl Acad Sci U S A (2008) 3.21
Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors. Mol Pharmacol (2007) 2.64
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. Neuropsychopharmacology (2012) 2.28
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron (2006) 2.00
The N terminus of monoamine transporters is a lever required for the action of amphetamines. J Biol Chem (2010) 1.58
Concentrative export from the endoplasmic reticulum of the gamma-aminobutyric acid transporter 1 requires binding to SEC24D. J Biol Chem (2007) 1.49
Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia? Biochem Pharmacol (2007) 1.44
Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol Pharmacol (2005) 1.42
Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci (2008) 1.41
Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies. Proteins (2009) 1.32
Membrane localization is critical for activation of the PICK1 BAR domain. Traffic (2008) 1.25
Identification of an additional interaction domain in transmembrane domains 11 and 12 that supports oligomer formation in the human serotonin transporter. J Biol Chem (2003) 1.25
Unifying concept of serotonin transporter-associated currents. J Biol Chem (2011) 1.24
Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3. J Neurosci (2009) 1.22
The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter. Mol Pharmacol (2010) 1.21
Charge movement of a voltage-sensitive fluorescent protein. Biophys J (2009) 1.21
Two discontinuous segments in the carboxyl terminus are required for membrane targeting of the rat gamma-aminobutyric acid transporter-1 (GAT1). J Biol Chem (2004) 1.20
The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters. J Biol Chem (2012) 1.19
SLC6 transporters: structure, function, regulation, disease association and therapeutics. Mol Aspects Med (2013) 1.18
Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines. Neuropharmacology (2005) 1.17
Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome. J Biol Chem (2012) 1.14
Reticulon RTN2B regulates trafficking and function of neuronal glutamate transporter EAAC1. J Biol Chem (2007) 1.14
Mutational analysis of the high-affinity zinc binding site validates a refined human dopamine transporter homology model. PLoS Comput Biol (2013) 1.14
The conserved glutamate (Glu136) in transmembrane domain 2 of the serotonin transporter is required for the conformational switch in the transport cycle. J Biol Chem (2006) 1.13
Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter. J Biol Chem (2004) 1.13
Sec24- and ARFGAP1-dependent trafficking of GABA transporter-1 is a prerequisite for correct axonal targeting. J Neurosci (2008) 1.12
The role of zinc ions in reverse transport mediated by monoamine transporters. J Biol Chem (2002) 1.11
The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C. J Biol Chem (2011) 1.11
A quantitative model of amphetamine action on the 5-HT transporter. Br J Pharmacol (2014) 1.11
Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1. J Biol Chem (2002) 1.09
Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter. J Biol Chem (2010) 1.08
Glycine transporter dimers: evidence for occurrence in the plasma membrane. J Biol Chem (2008) 1.07
Imaging genetics of mood disorders. Neuroimage (2010) 1.06
Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux. J Biol Chem (2012) 1.04
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine. Biol Chem (2011) 1.03
Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs. Eur J Pharmacol (2012) 1.02
Fluorescence resonance energy transfer in the study of cancer pathways. Curr Opin Oncol (2003) 1.02
Signal-dependent export of GABA transporter 1 from the ER-Golgi intermediate compartment is specified by a C-terminal motif. J Cell Sci (2008) 1.00
The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking. J Neurosci (2011) 1.00
Nano-positioning system for structural analysis of functional homomeric proteins in multiple conformations. Structure (2012) 0.99
Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate. Proc Natl Acad Sci U S A (2013) 0.99
Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine. J Biol Chem (2010) 0.97
Peptide-based interactions with calnexin target misassembled membrane proteins into endoplasmic reticulum-derived multilamellar bodies. J Mol Biol (2008) 0.95
Switching the clientele: a lysine residing in the C terminus of the serotonin transporter specifies its preference for the coat protein complex II component SEC24C. J Biol Chem (2013) 0.95
Interaction between fast and ultra-slow inactivation in the voltage-gated sodium channel. Does the inactivation gate stabilize the channel structure? J Biol Chem (2002) 0.95
Single molecule analysis reveals coexistence of stable serotonin transporter monomers and oligomers in the live cell plasma membrane. J Biol Chem (2014) 0.94
Probing binding pocket of serotonin transporter by single molecular force spectroscopy on living cells. J Biol Chem (2011) 0.94
The large extracellular loop of organic cation transporter 1 influences substrate affinity and is pivotal for oligomerization. J Biol Chem (2011) 0.94
Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding. J Biol Chem (2012) 0.93
Enhanced serotonin transporter function during depression in seasonal affective disorder. Neuropsychopharmacology (2007) 0.93
Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. J Clin Invest (2014) 0.92
The endoplasmic reticulum exit of glutamate transporter is regulated by the inducible mammalian Yip6b/GTRAP3-18 protein. J Biol Chem (2007) 0.92
Subtype-specific differences in corticotropin-releasing factor receptor complexes detected by fluorescence spectroscopy. Mol Pharmacol (2009) 0.91
A molecular switch between the outer and the inner vestibules of the voltage-gated Na+ channel. J Biol Chem (2010) 0.90
Sensing charges of the Ciona intestinalis voltage-sensing phosphatase. J Gen Physiol (2013) 0.90
Structure and regulatory interactions of the cytoplasmic terminal domains of serotonin transporter. Biochemistry (2014) 0.90
The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization. FASEB J (2011) 0.89
N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents. J Neurochem (2008) 0.88
A membrane network of receptors and enzymes for adenine nucleotides and nucleosides. Biochim Biophys Acta (2008) 0.88
Oligomerization of the {gamma}-aminobutyric acid transporter-1 is driven by an interplay of polar and hydrophobic interactions in transmembrane helix II. J Biol Chem (2004) 0.88
Actovegin®: a biological drug for more than 5 decades. Wien Med Wochenschr (2011) 0.86
Glycosylation of Twisted Gastrulation is Required for BMP Binding and Activity during Craniofacial Development. Front Physiol (2011) 0.85
Speeding the recovery from ultraslow inactivation of voltage-gated Na+ channels by metal ion binding to the selectivity filter: a foot-on-the-door? Biophys J (2007) 0.85
Fiber type conversion alters inactivation of voltage-dependent sodium currents in murine C2C12 skeletal muscle cells. Am J Physiol Cell Physiol (2004) 0.85
A repulsion mechanism explains magnesium permeation and selectivity in CorA. Proc Natl Acad Sci U S A (2014) 0.84
Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile. Toxicol Appl Pharmacol (2013) 0.84
Involvement of serotonin transporter extracellular loop 1 in serotonin binding and transport. Mol Membr Biol (2008) 0.83
Selectivity filter residues contribute unequally to pore stabilization in voltage-gated sodium channels. Biochemistry (2005) 0.82
C2C12 skeletal muscle cells adopt cardiac-like sodium current properties in a cardiac cell environment. Am J Physiol Heart Circ Physiol (2006) 0.82
Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine. J Pharmacol Exp Ther (2013) 0.81
Probing the Selectivity of Monoamine Transporter Substrates by Means of Molecular Modeling. Mol Inform (2013) 0.81
A combined approach using transporter-flux assays and mass spectrometry to examine psychostimulant street drugs of unknown content. ACS Chem Neurosci (2012) 0.80
Pore-exposed tyrosine residues of P-glycoprotein are important hydrogen-bonding partners for drugs. Mol Pharmacol (2013) 0.79
Intramolecular cross-linking in a bacterial homolog of mammalian SLC6 neurotransmitter transporters suggests an evolutionary conserved role of transmembrane segments 7 and 8. Neuropharmacology (2005) 0.78
A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1). J Med Chem (2015) 0.77
Heterocyclic Analogues of Modafinil as Novel, Atypical Dopamine Transporter Inhibitors. J Med Chem (2017) 0.75
Occupancy of the zinc-binding site by transition metals decreases the substrate affinity of the human dopamine transporter by an allosteric mechanism. J Biol Chem (2017) 0.75
Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications. Eur J Neurosci (2017) 0.75